Abstract
This study examines how often medicines regulators in Australia, Canada, the United Kingdom, and the United States were concordant in their decisions to issue safety advisories on approved prescription medicines.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have